TEVA PHARMACEUTICAL INDUSTRIES LTD
Qualité des données : 100%
TEVJF
NYSE
Manufacturing
Chemicals
28,36 €
0,00 €
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-44,56%
Croissance
Revenue Growth (5Y)
-44,56%
En dessous de la moyenne du secteur (1,72%)
Revenue (1Y)-90,93%
Earnings (1Y)N/A
FCF Growth (3Y)9,79%
Qualité
Return on Equity
20,03%
Au-dessus de la moyenne du secteur (-54,68%)
ROIC7,62%
Net Margin94,00%
Op. Margin143,80%
Sécurité
Debt / Equity
N/A
Current Ratio1,11
Interest Coverage2,35
Valorisation
PE (TTM)
31,71
Au-dessus de la moyenne du secteur (-1,50)
P/B Ratio6,17
EV/EBITDA13,46
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -44,56% annually over 5 years
ROE of 20,03% indicates high profitability
Net margin of 94,00% shows strong profitability
Generating 1,65 B in free cash flow
P/E of 31,71 — premium valuation
PEG of 0,89 suggests growth is underpriced
Price History
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Growth
Rev 5Y: -44,56% · Earnings 1Y: N/A
Growth
Rev 5Y: -44,56% · Earnings 1Y: N/A| Revenue Growth (1Y) | -90,93% | Revenue Growth (3Y) | -69,23% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -44,56% | Earnings Growth (5Y) | 35,60% |
Profitability
ROE: 20,03% · Net Margin: 94,00%
Profitability
ROE: 20,03% · Net Margin: 94,00%| Revenue (TTM) | 1,50 B | Net Income (TTM) | 1,41 B |
| ROE | 20,03% | ROA | 3,53% |
| Gross Margin | 595,87% | Operating Margin | 143,80% |
| Net Margin | 94,00% | Free Cash Flow (TTM) | 1,65 B |
| ROIC | 7,62% | FCF Growth (3Y) | 9,79% |
Safety
D/E: N/A · Current: 1,11
Safety
D/E: N/A · Current: 1,11| Debt / Equity | N/A | Current Ratio | 1,11 |
| Interest Coverage | 2,35 | Asset Turnover | 0,04 |
| Working Capital | 1,25 B | Tangible Book Value | -12,63 B |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | -36,65% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
Valuation
P/E: 31,71 · EV/EBITDA: 13,46
Valuation
P/E: 31,71 · EV/EBITDA: 13,46| P/E Ratio | 31,71 | Forward P/E | N/A |
| P/B Ratio | 6,17 | P/S Ratio | 29,81 |
| PEG Ratio | 0,89 | Forward PEG | N/A |
| EV/EBITDA | 13,46 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,61 | Fwd Earnings Yield | N/A |
| FCF Yield | 3,69% | ||
| Market Cap | 44,72 B | Enterprise Value | 42,51 B |
Per Share
EPS: 1,21 · FCF/Share: 1,36
Per Share
EPS: 1,21 · FCF/Share: 1,36| EPS (Diluted TTM) | 1,21 | Revenue / Share | 1,24 |
| FCF / Share | 1,36 | OCF / Share | 1,36 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | 33,58% |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 116,95% · CapEx/Rev: N/A
Efficiency
FCF Conv: 116,95% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 116,95% |
| SBC-Adj. FCF | 1,51 B | Growth Momentum | -46,37 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,50 B | 16,54 B | 15,85 B | 14,93 B | 15,88 B |
| Net Income | 1,41 B | -1,64 B | -559,00 M | -2,35 B | 417,00 M |
| EPS (Diluted) | 1,21 | -1,45 | -0,50 | -2,12 | 0,38 |
| Gross Profit | 8,94 B | 8,06 B | 7,65 B | 6,97 B | 7,59 B |
| Operating Income | 2,16 B | -303,00 M | 433,00 M | -2,10 B | 1,72 B |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | 98,00 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 1,00 B | 1,06 B | 1,15 B | 1,31 B | 1,33 B |
| Interest Expense | 916,00 M | 1,00 B | 1,03 B | 930,00 M | 891,00 M |
| Income Tax | -180,00 M | 676,00 M | -7,00 M | -638,00 M | 211,00 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40,75 B | 39,33 B | 43,48 B | 44,01 B | 47,67 B |
| Total Liabilities | 32,83 B | 33,61 B | 35,35 B | 35,32 B | 36,42 B |
| Shareholders' Equity | 7,91 B | 5,37 B | 7,51 B | 7,90 B | 10,28 B |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 3,56 B | 3,30 B | 3,23 B | 2,80 B | 2,17 B |
| Current Assets | 13,95 B | 12,55 B | 12,49 B | 12,05 B | 12,57 B |
| Current Liabilities | 13,46 B | 12,80 B | 12,25 B | 11,47 B | 11,03 B |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 31,7 | -1,5 |
| P/B | 6,2 | 1,6 |
| ROE % | 20,0 | -54,7 |
| Net Margin % | 94,0 | -41,5 |
| Rev Growth 5Y % | -44,6 | 1,7 |
| D/E | — | 0,3 |
Historique des dividendes
Historique des dividendes
Derniers paiements par action (plus récent en premier).
| Ex-dividende | Paiement | Montant / action |
|---|---|---|
| Jun 05, 2017 | — | 0,35 € |
| May 24, 2016 | — | 0,34 € |
| May 19, 2015 | — | 0,34 € |
| Nov 17, 2014 | — | 0,32 € |
| Aug 21, 2014 | — | 0,34 € |
| May 20, 2014 | — | 0,35 € |
| Feb 24, 2014 | — | 0,35 € |
{"event":"ticker_viewed","properties":{"ticker":"TEVJF","listing_kind":"stock","pathname":"/stocks/tevjf","exchange":"NYSE","country":"US"}}